Question 1

Has Raymond Manning received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $3,752,062 in general payments to Raymond Manning across 629 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Raymond Manning did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Raymond Manning come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Sunovion Pharmaceuticals Inc.	198	$822,742
Teva Pharmaceuticals USA, Inc.	61	$603,996
AbbVie	38	$522,591
Hoffmann-la Roche Limited	6	$335,270
Biogen	4	$326,019
Boehringer Ingelheim	10	$310,624
Alkermes, Inc.	123	$216,257
Sage Therapeutics, LLC	22	$96,505
Roche TCRC, Inc.	8	$87,343
Takeda Pharmaceuticals U.S.A., Inc.	11	$76,805
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	5	$66,901
Tolmar, Inc.	3	$65,814
GW Research Limited	15	$60,621
Corcept Therapeutics	4	$60,033
Otsuka Pharmaceutical Development & Commercialization, Inc.	3	$48,470
Boehringer Ingelheim International GmbH	55	$21,327
Jazz Pharmaceuticals Inc.	4	$19,067
Sumitomo Pharma America, Inc.	32	$8,714
Boehringer Ingelheim RCV GmbH & Co KG	26	$2,463
Merck	1	$500

Raymond Manning

Payments from drug & device makers

Who reported the general payments

How this compares

Other psychiatry in Pico Rivera